A Lactobacillus plantarum HYZQF 3DS-1 and its application in preparing products for preventing Alzheimer's disease

By regulating the intestinal flora and increasing the content of active ingredients in the intestines through Lactobacillus plantarum HYZQF 3DS-1 probiotic, the prevention of Alzheimer's disease has been solved, and the effects of neuroprotection and cognitive function improvement have been achieved.

CN118652826BActive Publication Date: 2024-11-05SHANDONG HUANYI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411155010.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-22
Publication Date
2024-11-05
Estimated Expiration
2044-08-22

AI Technical Summary

Technical Problem

Current technologies have failed to effectively utilize probiotics to regulate gut microbiota, leading to the occurrence and progression of Alzheimer's disease, and there is a lack of effective prevention strategies.

Method used

Probiotic agents were prepared using Lactobacillus plantarum HYZQF 3DS-1. The agents were prepared into powder or liquid via freeze-drying and then applied to pharmaceuticals, health products, food, and feed additives to regulate the balance of intestinal microbiota and increase the content of lycopene, naringenin, carotenoids, vitamin D, and ergothionein in the intestine.

Benefits of technology

Lactobacillus plantarum HYZQF 3DS-1 multiplies in the gut, providing an essential amount of endogenous active ingredients with antioxidant, anti-inflammatory and neuroprotective effects, improving cognitive function and preventing the onset and progression of Alzheimer's disease.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention belongs to the field of microorganisms and biomedicine technology, and specifically relates to a Lactobacillus plantarum HYZQF 3DS-1 and its application in preparing a product for preventing Alzheimer's disease. Lactobacillus plantarum ) HYZQF 3DS-1, the results of the study showed that Lactobacillus plantarum HYZQF 3DS-1 can sustainably provide the necessary amount of lycopene, naringenin, carotenoids, vitamin D and ergothioneine in the process of intestinal reproduction and growth. Therefore, the Lactobacillus plantarum HYZQF 3DS-1 provided by the present invention can be used to prepare products for preventing Alzheimer's disease.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of microorganisms, and particularly relates to a Lactobacillus plantarum HYZQF 3DS-1 and an application thereof in preparing a product for preventing Alzheimer's disease. Background Art

[0002] The information disclosed in this background technology section is only intended to enhance the understanding of the overall background of the invention, and should not necessarily be regarded as an admission or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.

[0003] Alzheimer's disease (AD) is one of the most common age-related neurodegenerative diseases, and its clinical manifestations include progressive memory impairment, cognitive dysfunction and language impairment. As a common, frequently occurring and high-burden disease in the elderly, AD has become one of the areas of greatest concern worldwide. The pathogenesis of AD is still unclear, but the main neuropathological features of AD include neuritic plaques (senile plaques) caused by extracellular amyloid-β (Aβ), neurofibrillary tangles caused by hyperphosphorylation of intracellular Tau protein, and loss of neurons and synapses, leading to the clinically observed loss of memory and cognitive abilities in patients.

[0004] There is a certain relationship between intestinal flora and Alzheimer's disease. There is a two-way connection between human intestinal flora and the brain, which is called the brain-gut axis. Intestinal flora can affect brain function and host behavior, and regulate brain functions such as learning, memory, and cognitive ability. However, with age, the diversity of intestinal flora decreases, the number of probiotics also decreases accordingly, and intestinal dysbiosis leads to corresponding impaired learning, memory, and cognitive abilities, which directly affects the occurrence and progression of Alzheimer's disease. Intestinal flora can secrete a large amount of amyloid substances and lipopolysaccharide (LPS), which can lead to changes in signaling pathways and the production of proinflammatory factors, thereby leading to the deposition of Aβ and Tau proteins, and then leading to the onset of Alzheimer's disease.

[0005] Probiotics, as an effective means of regulating the balance of intestinal flora, can not only optimize intestinal health, but also show potential neuroprotective effects. Some specific probiotic strains have been found to have a positive impact on the central nervous system through multiple mechanisms, including enhancing intestinal barrier function, reducing systemic inflammatory response, regulating immune function, and directly affecting nervous system function through neuroactive substances.

[0006] Therefore, developing more probiotics that can effectively prevent Alzheimer's disease can provide new strategies for the prevention and treatment of Alzheimer's disease. Summary of the invention

[0007] In order to overcome the above problems, the present invention provides a Lactobacillus plantarum HYZQF 3DS-1 and application thereof in preparing a product for preventing Alzheimer's disease.

[0008] In order to achieve the above technical objectives, the present invention adopts the following technical solutions:

[0009] The first aspect of the present invention provides a plant lactobacillus ( Lactobacillus plantarum )HYZQF3DS-1, deposited in China Center for Type Culture Collection, the deposit date is March 22, 2019, and the deposit number is CCTCCNO: M 2019193.

[0010] The second aspect of the present invention provides a microbial agent, wherein the microbial agent is the plant lactobacillus ( Lactobacillus plantarum ) The bacterial liquid or powder of HYZQF 3DS-1 is the active ingredient.

[0011] In one or more embodiments, Lactobacillus plantarum ( Lactobacillus plantarum ) The bacterial powder of HYZQF 3DS-1 was prepared by freezing and freeze-drying, containing 1×10 7 ~1×10 14 / g of inactivated bacteria.

[0012] In one or more embodiments, Lactobacillus plantarum ( Lactobacillus plantarum ) The bacterial solution of HYZQF 3DS-1 is made by diluting Lactobacillus plantarum with sterile saline ( Lactobacillus plantarum )HYZQF 3DS-1 freeze-dried bacterial powder was obtained.

[0013] The third aspect of the present invention provides the plant lactobacillus ( Lactobacillus plants ) Use of HYZQF 3DS-1 and / or the microbial agent described in the second aspect in the preparation of products for preventing Alzheimer's disease.

[0014] In one or more embodiments, the product includes any one of a drug and a pharmaceutical composition.

[0015] A fourth aspect of the present invention provides the plant lactobacillus ( Lactobacillus plants ) Use of HYZQF 3DS-1 and / or the microbial agent described in the second aspect in the preparation of products for regulating the balance of intestinal microbial flora and promoting digestion.

[0016] In one or more embodiments, the product includes any one of a medicine and a pharmaceutical composition, a health product, a food or a food additive, and a feed or a feed additive.

[0017] A fifth aspect of the present invention provides the plant lactobacillus ( Lactobacillus plants ) Use of HYZQF 3DS-1 and / or the microbial agent described in the second aspect in any of the following:

[0018] A1) Increase the content of lycopene during intestinal reproduction;

[0019] A2) Preparation of products for increasing the lycopene content in intestinal reproduction processes;

[0020] A3) Increase the content of naringenin during intestinal reproduction;

[0021] A4) preparing products for increasing the content of naringenin in intestinal reproduction;

[0022] A5) Increase the content of carotenoids during intestinal reproduction;

[0023] A6) Preparation of products for increasing the carotenoid content in intestinal reproduction processes;

[0024] A7) Increase the content of vitamin D during intestinal reproduction;

[0025] A8) Preparation of products for increasing the content of vitamin D in intestinal reproduction;

[0026] A9) Increase the content of ergothioneine during intestinal reproduction;

[0027] A10) Preparation of products for increasing ergothioneine content in intestinal reproduction processes.

[0028] In one or more embodiments, the product includes any one of a drug and a pharmaceutical composition.

[0029] The beneficial effects of the present invention are:

[0030] Based on the isolation of Lactobacillus plantarum from fresh tomato pulp ( Lactobacillus plantarum) HYZQF 3DS-1, the results showed that Lactobacillus plantarum HYZQF 3DS-1 can sustainably provide the necessary amount of lycopene, naringenin, carotenoids, vitamin D and ergothioneine in the process of intestinal reproduction and growth. Among them, lycopene has antioxidant, anti-inflammatory and immunomodulatory properties; lycopene can cross the blood-brain barrier, indicating that the consumption of lycopene plays an important role in maintaining neuronal health or preventing or alleviating neurological damage caused by oxidative stress. Naringenin has antioxidant, anti-proliferative and anti-inflammatory activities, which can protect neurons from oxidative damage, reduce lipid peroxidation, inhibit the formation of protein fibers of β-amyloid protein, offset cell lysis and inflammatory cascade pathways, and therefore has the effect of preventing Alzheimer's disease. Carotenoids affect the pathophysiology of Alzheimer's disease through multiple mechanisms and have neuroprotective effects, such as inhibiting Aβ synthesis and accumulation, anti-neurotransmission and anti-inflammatory effects; supplementation of carotenoids can reduce Aβ peptides and oxidative stress biomarkers; it can also improve Aβ clearance in the brain, change neuroinflammatory responses and cognitive performance. Vitamin D reduces hippocampal degenerative processes and participates in the detoxification process by interacting with reactive oxygen and reactive nitrogen and regulating the activity of γ-glutamyl transpeptidase; Vitamin D can reduce the accumulation of Aβ by stimulating the innate immune system, especially the phagocytosis and removal of amyloid, thereby preventing Alzheimer's disease. Ergothioneine is a naturally occurring amino acid with excellent in vitro antioxidant properties, which can protect the brain from oxidative damage and neuroinflammation, target neurodegenerative diseases such as mitochondrial dysfunction and toxic amyloid accumulation, and even promote neurogenesis. Therefore, the plant lactobacillus HYZQF3DS-1 provided by the present invention can be used to prepare products for preventing Alzheimer's disease. DETAILED DESCRIPTION

[0031] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used in the present invention have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.

[0032] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.

[0033] The plant lactobacillus provided by the present invention ( Lactobacillus plantarum)HYZQF 3DS-1, deposited in China Center for Type Culture Collection, the deposit date is March 22, 2019, and the deposit number is CCTCC NO: M 2019193.

[0034] The bacterium was isolated by Cao Chongren from fresh tomato pulp in Laixi City, Qingdao City in July 1999 and was identified as Lactobacillus plantarum by 16srRNA method. The nucleotide sequence of Lactobacillus plantarum HYZQF 3DS-1 is shown in SEQ ID NO.1.

[0035] The nucleotide sequence is as follows:

[0036]

[0037] Example 1

[0038] Preparation of lyophilized powder of inactivated bacterial metabolites of Lactobacillus plantarum HYZQF 3DS-1:

[0039] (1) Bacteria activation

[0040] Bacterial strain culture: Expansion culture of bacterial strains preserved in -80℃ refrigerator.

[0041] Preparation of culture medium: 13 g oligofructose, 2 g lactitol, 5 g beef extract powder, 1.6 g sodium acetate, 0.5 mL Tween-800, 0.5 g potassium dihydrogen phosphate, 1000 mL tap water, pH adjusted to 7.0 (alkaline solution adjustment).

[0042] Operation: Add the oligofructose and other raw materials in the above formula into 1000 mL of water in the formula without any distinction, stir for 10 minutes to dissolve, and then divide into test tubes, each test tube contains 5.0 mL, seal with kraft paper and put in a medical sterilizer for sterilization at 0.1-0.12 MPa for 20 minutes. The culture medium is ready.

[0043] Inoculation: Under sterile conditions (clean bench), open the -80 ℃ low-temperature refrigerator to store the frozen tube of bacteria, and melt it at room temperature. Then take one sterilized test tube culture medium, add 0.5 mL of the dissolved bacterial solution into the test tube, seal the tube mouth with kraft paper, shake it gently by hand, and place it in a constant temperature incubator at 37 ℃ for 16 hours. This is called expansion culture medium.

[0044] (2) Preparation of primary bacterial culture liquid:

[0045] Primary seed culture formula: inulin 7 g, peptone 4 g, beef extract powder 6 g, arginine 1.7 g, sodium acetate 0.6 g, leucine 1.5 g, Tween-80 1 mL, tap water 1000 mL.

[0046] Operation: Add the above raw materials into 1000 mL of tap water without any distinction, start the blender, and stir for 10 minutes to dissolve them all. This is called the primary seed culture solution.

[0047] Add the stirred and dissolved first-level seed culture solution into the conical flask according to the dosage, then wrap the bottle mouth with 6 layers of gauze and one layer of kraft paper, and put it into the sterilizer for sterilization. Before sterilization, first open the exhaust valve on the sterilizer and close it when a small amount of steam is discharged. When the pressure on the sterilizer reaches 0.05 MPa, open the exhaust valve on the sterilizer to exhaust for 6~8 minutes, then close the exhaust valve and continue heating. When the steam pressure in the sterilizer reaches 0.1~0.12MPa, start timing. The sterilization time is 20 min. After completion, leave the heat source and let it cool down naturally. When the pressure gauge on the sterilizer returns to zero, open the sterilizer, take out the sterilized culture medium and put it into the clean bench for natural cooling. When the temperature drops to 37 ℃, transfer the above cultured expansion culture solution to the conical flask containing the sterilized culture solution. The inoculation amount is 0.5%, that is, 100 mL of first-level seed culture solution and 0.5 mL of expansion culture solution. mL. After completion, seal the bottle mouth with the original gauze and kraft paper, shake it slightly by hand to mix the inoculated bacteria and culture solution evenly, and then place it in a constant temperature box and culture it at 37 ℃ for 18 h. This is called the primary culture solution.

[0048] (3) Preparation of seed tank strains:

[0049] Sterilization of fermentation equipment, pipelines and sterile filtration systems:

[0050] First, open the valves of all inlet and outlet pipelines and sterile air pipelines, and pass 0.12~0.14 MPa steam. Allow the steam to connect with the pipeline valves and discharge a small amount of steam. Ventilate for 40 minutes, then close the valves of all inlet and outlet pipelines and set aside.

[0051] Sterilization of empty seed tanks and fermentation tanks:

[0052] Close all valves, open the drain valve at the bottom of the tank and the drain valve in the tank interlayer, open the direct steam valve to introduce 0.12~0.14 MPa steam into the pipe, start timing when the temperature in the tank reaches 121 ℃, the sterilization time is 40 min, then close the drain valve at the bottom of the tank and the drain valve in the interlayer, and the temperature in the tank will naturally drop to 37 ℃ for standby use.

[0053] Seed pot culture:

[0054] Formula: inulin 1%, glucose 1%, isomaltulose 2%, casein peptone 0.9%, dipotassium hydrogen phosphate 0.2%, proline 0.6%, sodium acetate 0.2%, arginine 0.6%, Tween-80 0.1%, polyether defoamer 0.1%, tap water 93.3%.

[0055] Specific operation: First, pour the tap water used in the formula into the sterilized seed tank, start the mixer, add the raw materials required in the formula respectively (the order of addition does not matter), then stir continuously and pass steam for heating. First, use the steam in the tank interlayer to heat to 95°C, then switch to direct steam heating. When the temperature in the tank reaches 121°C, maintain it for 20 minutes to achieve the sterilization effect, then turn off the steam, and start cooling through the tap water in the tank interlayer. When the temperature in the tank reaches 37°C, it is ready for use. This is called seed culture medium. Then inoculate the above-cultured first-level bacterial culture solution into the seed tank under sterile conditions. The inoculation amount is 3% of the culture medium in the tank. 100 kg of seed tank culture medium can be inoculated with 3 kg of first-level bacterial solution. Then cover the inoculation cap on the tank and start stirring and culturing. The culture conditions are: temperature 37°C, stirring speed 140r / min, tank pressure 0.05 MPa, and culture time 12 h to meet the requirements. If the tank body is lowered, sterile air can be introduced to maintain the tank pressure. If the tank pressure is too high, the air release valve on the tank top can be used to adjust it. This is called seed tank culture.

[0056] (4) Fermentation

[0057] Formula: 2% glucose, 0.6% casein peptone, 1.5% xylo-oligosaccharide, 1.4% fructo-oligosaccharide, 2% soybean oligopeptide, 1% yeast extract powder, 1.2% sodium acetate, 0.2% Tween-80, 0.4% threonine, 0.4% dipotassium hydrogen phosphate, 0.1% polyether defoamer, and 89.2% tap water.

[0058] Specific operation: First, add the tap water used in the formula into the sterilized fermentation tank, start the mixer, add the raw materials used in the formula into the fermentation tank (the order of addition is not important), and then pass steam for heating. First, use the interlayer steam to heat to 95 ℃, and then switch to direct steam heating. When the temperature in the tank reaches 121 ℃, start timing, and keep it for 30 minutes to achieve the sterilization effect, and then cool it down with the interlayer tap water. When the temperature in the tank drops to 37 ℃, start to inoculate the strain. Before inoculation, first increase the tank pressure of the seed tank to 0.1 MPa, and keep the tank pressure of the fermentation tank at 0.05 MPa, then open the inoculation pipeline valve, and transport the seeds cultured in the seed tank to the fermentation tank by pressure difference, and then close the inoculation channel valve.

[0059] The inoculation amount is 3 kg of bacteria cultured in the seed tank for every 100 kg of culture medium in the fermentation tank. The culture conditions are: 0-5h culture temperature 37 °C, stirring speed 120 r / min, tank pressure maintained at 0.05 MPa, and the acid and alkali automatic control system is used to maintain the pH value at 6.5 during the fermentation process. If the tank pressure drops, sterile air can be introduced to maintain the tank pressure until the fermentation is completed. The total fermentation time is 30 hours, and then the temperature is lowered to 20 °C. This is the fermentation broth. 2% trehalose is added to the fermentation broth and kept at 120 °C for 6 seconds for UHT inactivation treatment.

[0060] (5) Centrifugation of fermentation broth

[0061] The fermentation liquid is pumped into a storage tank for centrifugation. Operation: Start the centrifuge, adjust the speed to 10000 r / min, centrifuge at a feed rate of 6 kg / min, collect the inactivated wet bacterial sludge metabolites after centrifugation, and freeze-dry the collected inactivated wet bacterial sludge metabolites.

[0062] (6) Freeze-drying of bacterial sludge metabolites

[0063] Preparation of bacterial suspension: Take 1000 g of inactivated wet bacterial sludge metabolites, add 4000 mL of sterile saline, 300 g of maltodextrin, 1500 g of anhydrous glucose, 10 g of zinc sulfate, and 80 g of skimmed milk powder.

[0064] Operation: First, take 2500 mL of sterile saline in the formula, add maltodextrin and stir to dissolve, then add 1000 g of inactivated wet bacterial sludge metabolites, and then add the remaining sterile saline and anhydrous glucose and auxiliary materials in the formula and stir well, which is called a suspension. The suspension is freeze-dried and the moisture content is finally controlled to 4%, which becomes a freeze-dried powder of inactivated bacterial metabolites.

[0065] After testing, the freeze-dried powder obtained in Example 1 had a content of inactivated bacteria of 150 billion / g.

[0066] Example 2

[0067] Metabolomics analysis of mouse feces was performed using ultra-performance liquid chromatography-tandem mass spectrometry (LC-MS).

[0068] Experimental plan: The mice were divided into a control group and an experimental group. The control group was fed with normal food, while the experimental group was fed with 8×10 8The probiotic product containing inactivated bacterial cells and metabolites (freeze-dried powder obtained in Example 1) was fed for 30 days, 60 days, and 90 days. The fecal samples of the mice in the control group and the experimental group were placed in 400 μL of extraction solution (acetonitrile: methanol = 1: 1), vortexed for 30 s, extracted by low-temperature ultrasound for 30 min (5 ℃, 40 KHz), left to stand for 30 min at -20 ℃, placed in a 4 ℃ centrifuge, centrifuged at 13000 r / min for 15 min, the supernatant was taken, dried with nitrogen, re-dissolved with 120 μL of re-solution (acetonitrile: water = 1: 1), extracted by low-temperature ultrasound for 5 min (5 ℃, 40 KHz), placed in a 4 ℃ centrifuge, centrifuged at 13000 r / min for 5 min, and an appropriate amount of supernatant was taken for analysis. 10 μL of the sample supernatant was separated by a BEH C18 column (100 mm×2.1 mm id, 1.8 μm) and entered the mass spectrometry detection. The separation flow rate was 0.40 mL / min and the column temperature was 40 °C. After completion, the LC-MS raw data was transferred to the computer for processing and analysis. The mass spectrum information was matched with the public database, and the main metabolite information was obtained as shown in Table 1.

[0069] Table 1 Information of main metabolites

[0070]

[0071] The results showed that Lactobacillus plantarum HYZQF 3DS-1 can sustainably provide the necessary amount of endogenous lycopene, naringenin, carotenoids, vitamin D and ergothioneine during the growth and reproduction process in the intestine. Among them, lycopene has antioxidant, anti-inflammatory and immunomodulatory properties; lycopene can cross the blood-brain barrier, indicating that the consumption of lycopene plays an important role in maintaining neuronal health or preventing or alleviating neurological damage caused by oxidative stress. Naringenin has antioxidant, anti-proliferative and anti-inflammatory activities, which can protect neurons from oxidative damage, reduce lipid peroxidation, inhibit the formation of protein fibers of β-amyloid protein, offset cell lysis and inflammatory cascade pathways, and therefore has the effect of preventing Alzheimer's disease. Carotenoids affect the pathophysiology of Alzheimer's disease through multiple mechanisms and have neuroprotective effects, such as inhibiting Aβ synthesis and accumulation, anti-neurotransmission and anti-inflammatory effects; supplementation of carotenoids can reduce Aβ peptides and oxidative stress biomarkers; it can also improve Aβ clearance in the brain, change neuroinflammatory responses and cognitive performance. Vitamin D reduces hippocampal degenerative processes and participates in the detoxification process by interacting with reactive oxygen and reactive nitrogen and regulating the activity of γ-glutamyl transpeptidase; Vitamin D can reduce the accumulation of Aβ by stimulating the innate immune system, especially the phagocytosis and removal of amyloid, thereby preventing Alzheimer's disease. Ergothioneine is a naturally occurring amino acid with excellent in vitro antioxidant properties, which can protect the brain from oxidative damage and neuroinflammation, target neurodegenerative diseases such as mitochondrial dysfunction and toxic amyloid accumulation, and even promote neurogenesis. Therefore, the plant lactobacillus HYZQF 3DS-1 provided by the present invention can be used to prepare products for preventing Alzheimer's disease.

[0072] Example 3

[0073] Thirty male SD rats were selected and divided into a control group, a model group, and an experimental group. The control group did not establish an AD model, while the model group and the experimental group established an AD model (intraperitoneal injection of D-galactose once a day for 28 consecutive days). The control group and the model group were fed normally and gavaged with normal saline every day, while the experimental group was gavaged with 8×10 8 The probiotic product containing inactivated bacterial cells and metabolites (freeze-dried powder obtained in Example 1) was intragastrically administered for 28 consecutive days, and the learning and memory abilities of all rats were tested using the Morris water maze. The test included the following:

[0074] (1) Positioning navigation test:

[0075] One day before the experiment, rats were placed in the water maze for adaptation. The experiment lasted for 4 days. Rats were tested for entering the water from two quadrants every day, and their escape latency (the time from entering the water to finding a safe platform) was recorded. The test time was limited to 90 seconds. If the rat did not find the platform within 60 seconds, the rat was taken to the platform and allowed to stay on it for 30 seconds; if the rat found the platform within 60 seconds, it was also allowed to adapt to the platform for 30 seconds.

[0076] (2) Space exploration experiments:

[0077] On the fifth day of the experiment, the platform was removed and water was placed in the quadrant opposite to the original platform quadrant. The number of times the rat crossed the original platform position within 90 seconds was recorded.

[0078] (3) After the behavioral experiment, the rats were immediately decapitated, the skull was peeled off, the dura mater was opened, the brain was separated, and the hippocampus was quickly peeled off on ice. It was made into a 10% homogenate with physiological saline, centrifuged at 5000 r / min for 10 min, and the supernatant was stored at low temperature. The contents of acetylcholine (Ach), acetylcholinesterase (AchE), and choline acetyltransferase (ChAT) in the supernatant were detected by ELISA in strict accordance with the instructions of the detection kit.

[0079] The results of the positioning navigation test and the space exploration test are shown in Tables 2 and 3 , and the contents of Ach, AchE and ChAT are shown in Table 4 .

[0080] Table 2 Results of the positioning navigation experiment of rats in each group (X̄±S, s)

[0081]

[0082] Table 3 Results of spatial exploration experiment of rats in each group (X̄±S)

[0083]

[0084] Table 4 Ach, AchE and ChAT contents in rats of each group (X̄±S)

[0085]

[0086] It can be seen from Tables 2 and 3 that the Lactobacillus plantarum HYZQF 3DS-1 product prepared in Example 1 can improve the learning and memory ability of rats and prevent the occurrence of Alzheimer's disease.

[0087] It can be seen from Table 4 that the Lactobacillus plantarum HYZQF 3DS-1 product prepared in Example 1 can improve the levels of Ach, AchE and ChAT in the hippocampal tissue of rats and prevent the occurrence of Alzheimer's disease.

[0088] Example 4

[0089] (1) Experiment on regulating the function of mouse intestinal flora: The mice were divided into a control group and an experimental group, with 10 mice in each group. The control group was fed with normal food, while the experimental group was fed with 8×10 8 The probiotic product of inactivated bacterial cells and metabolites (freeze-dried powder obtained in Example 1) was obtained. Mouse feces were aseptically taken, weighed, diluted 10 times with a sterile diluent to make a uniform suspension, and then diluted 10 times in turn, and the appropriate dilution was selected and inoculated on each selective culture medium. The number of bacteria per gram of wet feces was calculated, and the logarithm was taken for statistical processing. 24 hours after the last administration of the probiotic product, rectal feces were taken, and the intestinal flora was detected as shown in Table 5.

[0090] Table 5 Suitable culture conditions and detection of intestinal flora (X̄±SD)

[0091]

[0092] According to Table 5, probiotic products can increase the number of beneficial bacteria (Bifidobacterium and Lactobacillus), while the number of harmful bacteria (Enterobacter and Enterococcus) did not increase but showed a slight downward trend, indicating that probiotics can regulate the function of the intestinal flora in mice.

[0093] (2) Gastrointestinal motility experiment in mice: The mice were divided into control group, model group and experimental group, with 10 mice in each group. The control group and model group were given distilled water by gavage, and the experimental group was given probiotic products containing inactivated bacteria and metabolites by gavage. After gavage for 15 days, the mice in each group were fasted for 16 hours. Then the model group and experimental group were given compound difenocolone by gavage, and the control group was given distilled water by gavage. 30 minutes later, the mice in each group were given Arabic gum ink by gavage. After 30 minutes, the mice were killed by cervical vertebral dissection. After cervical vertebral dissection, the abdomen was quickly cut open along the midline of the abdomen to separate the mesentery, and the intestinal tube was cut with the pylorus as the starting point and the ileocecal part as the end point. The small intestine was gently pulled into a straight line, and the intestinal tube length was measured as the "total length of the small intestine", and the length from the pylorus to the front of the ink was the "ink propulsion length". The ink propulsion rate was calculated according to the following formula. The ink propulsion rate of the small intestine is shown in Table 6.

[0094]

[0095] Table 6 Small intestinal ink propulsion rate (X̄±SD)

[0096]

[0097] As shown in Table 6, the intestinal motility inhibition model of mice was established by administering compound difenocool. Compared with the model group, the small intestinal ink propulsion rate of the experimental group increased, indicating that probiotic products can promote small intestinal digestion.

[0098] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A Lactobacillus plantarum ( Lactobacillus plantarum )HYZQF 3DS-1, deposited in China Center for Type Culture Collection, the deposit date is March 22, 2019, and the deposit number is CCTCC NO: M 2019193.

2. A microbial agent, characterized in that: The microbial agent is the plant lactobacillus ( Lactobacillus plantarum ) The bacterial liquid or powder of HYZQF 3DS-1 is the active ingredient.

3. The microbial agent according to claim 2, characterized in that Lactobacillus plantarum ( Lactobacillus plantarum ) The bacterial powder of HYZQF 3DS-1 was prepared by freezing and freeze-drying, containing 1×10 7 ~1×10 14 / g of inactivated bacteria.

4. The microbial agent according to claim 2, characterized in that Lactobacillus plantarum ( Lactobacillus plantarum ) The bacterial solution of HYZQF 3DS-1 is made by diluting Lactobacillus plantarum with sterile saline ( Lactobacillus plantarum )HYZQF 3DS-1 freeze-dried bacterial powder was obtained.

5. The plant lactobacillus according to claim 1 ( Lactobacillus plantarum ) Use of HYZQF 3DS-1 and / or the microbial agent described in any one of claims 2 to 4 in the preparation of products for preventing Alzheimer's disease.

6. The use according to claim 5, characterized in that The product includes any one of a drug and a pharmaceutical composition.

7. The plant lactobacillus according to claim 1 ( Lactobacillus plantarum ) Use of HYZQF 3DS-1 and / or the microbial agent described in any one of claims 2 to 4 in the preparation of products for regulating the balance of intestinal microbial flora and promoting digestion.

8. The use according to claim 7, characterized in that The product includes any one of medicines and pharmaceutical compositions, health products, foods or food additives, and feeds or feed additives.